The high number of nonsynonymous mutations in the pPCL cohort was not solely due to the high percentage of samples with maf translocations in this cohort, which are known to have an elevated number of mutations in MM patients due to an APOBEC mutational signature31,32. The gene discussed is MAF; the disease is Miyoshi myopathy.